Table 2 ART outcomes of women with endometriosis stage III-IV, previous endometrioma surgery and infertility without endometriosis

Total gonal-F dose, IU

2622 ± 543

2765 ± 552

2307 ± 685

<0.001^a

0.253

0.001

<0.001

No. of stimulation days

10.98 ± 1.42

10.76 ± 1.54

10.99 ± 1.67

0.663^a

Estradiol on day of HCG

1350 ± 849

1182 ± 547

1479 ± 784

0.065^a

No. of oocytes retrieved

6.97 ± 3.29

5.96 ± 2.40

8.82 ± 5.13

<0.001^a

0.245

0.005

0.001

No. of mature oocytes

5.63 ± 2.74

4.71 ± 2.29

6.92 ± 4.47

0.001^a

0.228

0.027

<0.001

Fertilization rate

0.75 ± 0.18

0.71 ± 0.19

0.73 ± 0.25

0.741^a

Embryo no.

4.15 ± 2.08

3.36 ± 1.68

5.08 ± 4.00

0.005^a

0.234

0.068

0.234

High-quality embryo

3.06 ± 1.42

2.44 ± 1.14

3.31 ± 2.47

0.071^a

No. of ET

3.10 ± 1.21

2.79 ± 1.25

3.05 ± 1.10

0.317^a

Implantation rate

0.42 ± 0.22

0.37 ± 0.12

0.40 ± 0.16

0.636^a

PR/cycle

23/63(36.5)

10/47(21.3)

78/175(44.6)

0.013^b

0.096

0.300

0.004

Biochemical pregnancy

6/23(26.1)

4/10(40.0)

14/78(17.9)

0.289^b

Clinical PR/cycle

17/63(27.0)

6/47(12.8)

64/175(36.6)

0.006^b

0.097

0.215

0.002

Live birth rate/cycle

15/63(23.8)

4/47(8.5)

51/175(29.1)

0.013^b

0.043

0.512

0.004

PR/ET

23/60(38.3)

10/44(22.7)

78/170(45.9)

0.019^b

0.135

0.365

0.006

Clinical PR/ET

17/60(28.3)

6/44(13.6)

64/170(37.6)

0.008^b

0.096

0.212

0.004

Live birth/ET

15/60(25.0)

4/44(9.1)

51/170(25.5)

0.017^b

0.043

0.510

0.006

Mmultiple birth/live birth

4/15(26.7)

0/4(0)

11/51(21.6)

0.591^b

Cancellation rate

3/63(4.8)

3/47(6.4)

5/175(2.9)

0.557^b